Senate leaders push back as White House moves to place NIH grant decisions under appointees
President Trump directed budget director Russ Vought to prepare an executive order that would create a new board to decide National Institutes of Health grant allocations, a board that would include NIH Director Jay Bhattacharya, Vought and a White House appointee. The White House and the Office of Management and Budget have begun drafting the order, with OMB Director Russell Vought arguing for political review of federal spending, including health research.
NIH Director Jay Bhattacharya opposed the effort, saying it conflicts with the agency’s mission to fund biomedical science. Senate Appropriations Committee chair Susan Collins and ranking Democrat Patty Murray issued a press release outlining legal and policy concerns, arguing the move would politicize grantmaking and run contrary to the purpose set by Congress.
How this was covered
- Left-leaning outlets covered this 17h later
- Centrist coverage is the most divided on this story
Why it matters
The outcome could reshape how billions in biomedical research funding are allocated, affecting scientific independence and public health studies.
How the sides frame it
LOW AGREEMENTLeft-leaning coverage portrays the proposal as a dangerous politicization and power grab that threatens scientific research, while right-leaning coverage presents it as a legitimate effort to tighten control and fund solid science, and centrist coverage reports that the plan appears to have been abandoned after Senate opposition.
LEFT
Trump’s attempt to place political appointees over NIH grants is framed as a terrifying power grab that politicizes and endangers scientific research.
CENTER
The executive order plan is framed as effectively dead or scrapped following pushback from Senate appropriators.
RIGHT
The move is framed as a necessary administrative step to ensure control over grant funding and support solid science.
The left emphasises
- described as a "power grab" and "terrifying"
- claims it would "censor" or politicize NIH funding
- highlights threats to biomedical innovation and university research
The right emphasises
- states the proposal would give the president direct control over grant allocations
- frames the action as correcting past priority errors and funding "solid science"
- emphasizes the administration’s intent to tighten oversight of biomedical research
How this story developed
- Sep 20 Trump moves to place NIH grant decisions under White House appointees
- Sep 24 Senate leaders issued a press release rejecting the White House’s plan.
Related stories
3 in this thread